Showing results (981-990 of 1,322) with videos related to

Sort By:
Pageof 133
IEEE Transactions on Ultrasonics, Ferroelectrics, and Frequency Control|June 4, 2021
High Frame Rate Volumetric Imaging of Microbubbles Using a Sparse Array and Spatial Coherence BeamformingLuxi Wei, Geraldi Wahyulaksana, Bram Meijlink, et al.
Oncotarget|April 23, 2016
MET expression during prostate cancer progressionEsther I Verhoef, Kimberley Kolijn, Maria J De Herdt, et al.
Neurosurgery|June 29, 2016
Diffusion Tensor Imaging: A Possible Biomarker in Severe Traumatic Brain Injury and Aneurysmal Subarachnoid Hemorrhage?Süleyman Sener, Wim Van Hecke, Bart F E Feyen, et al.
Gastroenterology|July 29, 2018
Equivalent Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening ProgramEls Wieten, Clasine M de Klerk, Annemieke van der Steen, et al.
Age and Ageing|March 2, 2023
The impact of the mySupport advance care planning intervention on family caregivers' perceptions of decision-making and care for nursing home residents with dementia: pretest-posttest study in six countriesLaura Bavelaar, Mandy Visser, Catherine Walshe, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 6, 2020
Peptide Binding to HLA-E Molecules in Humans, Nonhuman Primates, and Mice Reveals Unique Binding Peptides but Remarkably Conserved Anchor ResiduesPaula Ruibal, Kees L M C Franken, Krista E van Meijgaarden, et al.
Critical Reviews in Oncology/Hematology|April 22, 2017
FGFR a promising druggable target in cancer: Molecular biology and new drugsRut Porta, Roberto Borea, Andreia Coelho, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 19, 2017
Do Men and Women Need to Be Screened Differently with Fecal Immunochemical Testing? A Cost-Effectiveness AnalysisMiriam P van der Meulen, Atija Kapidzic, Monique E van Leerdam, et al.
Oncoimmunology|December 8, 2018
PRAME and HLA Class I expression patterns make synovial sarcoma a suitable target for PRAME specific T-cell receptor gene therapySietse J Luk, Dirk M van der Steen, Renate S Hagedoorn, et al.
Pilot and Feasibility Studies|March 13, 2020
Evaluating the feasibility and acceptability of the Namaste Care program in long-term care settings in CanadaSharon Kaasalainen, Paulette V Hunter, Vanina Dal Bello-Haas, et al.
Pageof 133